NVR vs VKTX · P/E 15, rev $4.21B vs $3.97B cap
NVR Inc (NVR) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
NVR currently screens at market cap $16.94B and trailing P/E 15.3. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the NVR and VKTX stock pages for the full models.
Not investment advice.